{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Beyond Lactulose: Treatment Options for Hepatic Encephalopathy

Activity Steps

Purpose of Activity

To provide information on current and emerging therapies in the treatment and management of hepatic encephalopathy (HE) in chronic liver disease.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Summarize the pathogenesis of HE in chronic liver disease and the conventional treatment for this condition.
  2. Specify current and emerging therapies for the treatment and management of HE, beyond lactulose.
Price: $15.00


  • ANCC 1.5 CH / 1.0 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Advanced Pharmacology Hours

Test Code: GN0519A
Published: May/Jun 2019
Expires: 6/4/2021
Required Passing Score: 13/18 (72%)
Authors: Vickey J. Said, MSN, aGaCNP-BC; Edith Garcia-Trujillo, MSN, aCNP-BC
Topics: Liver